Auro Laboratories logo

Auro Laboratories

AUROLABORATORIESLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹156 Cr
Volatility
Moderate
P/E Ratio
34.2
EBITDA
₹12.00 Cr
Return on Equity
7.62%
Debt to Equity
1.37
Book Value
₹74.36
EPS
₹12.48
52W High
₹317
52W Low
₹159

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

5
  • Stock is trading at 3.41 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -10.7% over past five years.
  • Company has a low return on equity of 10.7% over last 3 years.
  • Company might be capitalizing the interest cost

Growth Rate

Revenue Growth
62.69% higher than 3Y
Net Income Growth
94.44% higher than 3Y
Cash Flow Change
-57.97% higher than 3Y
ROE
78.04% higher than 3Y
ROCE
156% higher than 3Y
EBITDA Margin (Avg.)
81.27% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
10.18
13.41
17.98
12.06
5.72
3.1
3.05
7.4
2.77
8.84
9.39
9.83
8.77
Expenses
9.02
10.38
13.9
9.65
4.39
2.38
2.6
6.59
2.74
6.49
5.33
6.5
5.47
Operating Profit
1.16
3.03
4.08
2.41
1.33
0.72
0.45
0.81
0.03
2.35
4.06
3.33
3.3
OPM %
11.39%
22.6%
22.69%
19.98%
23.25%
23.23%
14.75%
10.95%
1.08%
26.58%
43.24%
33.88%
37.63%
Other Income
0.36
0.32
0.42
0.4
0.2
0.31
0.14
0.13
0.42
0.98
0.18
0.52
0.11
Interest
0.27
0.35
0.44
-0.32
0.25
0.28
0.25
0.3
0.28
0.96
1.52
1.49
1.37
Depreciation
0.27
0.27
0.27
0.28
0.27
0.27
0.27
0.29
0.27
0.65
0.98
0.9
0.91
PBT
0.98
2.73
3.79
2.85
1.01
0.48
0.07
0.35
-0.1
1.72
1.74
1.46
1.13
Tax %
27.55%
27.84%
27.7%
18.6%
24.75%
25%
28.57%
-11.43%
0%
58.14%
-12.07%
32.88%
7.08%
Net Profit
0.71
1.97
2.73
2.32
0.75
0.36
0.05
0.39
-0.11
0.72
1.95
0.97
1.05
EPS in Rs
1.14
3.16
4.38
3.72
1.2
0.58
0.08
0.63
-0.18
1.16
3.13
1.56
1.68
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
32.65
27.91
35.47
40.79
46.82
43.79
54.25
50.87
52.89
53.64
19.12
30.74
36.83
Expenses
29.71
25.11
31.03
34.43
39.83
37.51
43.01
46.24
48.5
42.96
15.99
20.53
23.79
Operating Profit
2.94
2.8
4.44
6.36
6.99
6.28
11.24
4.63
4.39
10.68
3.13
10.21
13.04
OPM %
9%
10.03%
12.52%
15.59%
14.93%
14.34%
20.72%
9.1%
8.3%
19.91%
16.37%
33.21%
35.41%
Other Income
0.24
0.42
0.53
0.51
0.96
0.97
0.76
1.09
0.94
1.5
0.93
1.66
1.79
Interest
1.66
1.66
1.18
1.21
0.87
0.58
0.46
0.83
0.81
0.74
1.08
4.25
5.34
Depreciation
0.72
0.68
0.86
0.93
1.01
1.02
1.04
1.02
1.07
1.09
1.1
2.81
3.44
PBT
0.8
0.88
2.93
4.73
6.07
5.65
10.5
3.87
3.45
10.35
1.88
4.81
6.05
Tax %
0%
0%
72.01%
25.16%
27.51%
27.96%
31.62%
26.61%
28.99%
24.64%
2.13%
26.61%
—
Net Profit
0.8
0.88
0.82
3.53
4.4
4.05
7.18
2.84
2.44
7.79
1.84
3.53
4.69
EPS in Rs
1.28
1.41
1.32
5.66
7.06
6.5
11.52
4.56
3.91
12.5
2.95
5.66
7.53
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.23
6.23
6.23
6.23
6.23
6.23
6.23
6.23
6.23
6.23
6.23
6.23
Reserves
1.47
2.35
3.18
6.75
11.18
15.27
22.35
25.29
27.97
35.73
36.74
40.12
Borrowings
16.41
12.62
4.95
9.2
8.09
3.16
3.16
13.78
6.41
26.25
45.01
63.31
Other Liabilities
4.67
4.49
12.45
8.23
7.97
7.68
10.15
9.66
15.38
17.52
11.11
11.42
Total Liabilities
28.78
25.69
26.81
30.41
33.47
32.34
41.89
54.96
55.99
85.73
99.09
121
Fixed Assets
9.8
9.13
13
13.02
14.59
14.24
13.56
13.61
12.62
22.15
21.06
75.18
CWIP
0.82
3.33
0.23
1.07
0.12
0.12
0.13
3.68
7.67
32.68
56.48
14.48
Investments
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.01
Other Assets
18.11
13.18
13.53
16.27
18.71
17.93
28.15
37.62
35.65
30.85
21.5
31.41
Total Assets
28.78
25.69
26.81
30.41
33.47
32.34
41.89
54.96
55.99
85.73
99.09
121
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.78
7.88
6.49
6.05
6.87
9.3
12.82
-6.59
3.28
18.81
5.02
2.11
Investing
-0.73
-2.44
-2.2
-3.04
-3.19
-2.21
-3.51
-5.34
-5.08
-38.67
-23.7
-14.78
Financing
0.53
-5.34
-3.81
-1.77
-1.83
-5.52
-0.46
9.79
-8.18
19.09
17.69
14.04
Net Cash Flow
-0.98
0.09
0.47
1.24
1.86
1.58
8.85
-2.14
-9.98
-0.77
-0.99
1.37
Free Cash Flow
-1.55
5.36
4.86
4.25
5.25
8.63
12.44
-11.2
-0.79
18.81
-18.78
-55.03
CFO/OP
-27
281
146
95
98
148
114
-142
75
176
184
21
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
94.8
66.04
79.13
74.9
66.26
48.18
49.12
97.65
85.57
91.11
179
109
Inventory Days
89.37
86.72
21.65
22
42.98
60.54
32.6
47.32
120
113
145
816
Days Payable
56.12
72.03
80.26
78.26
66.19
70.67
73.51
54.12
117
85.34
246
282
Cash Conversion Cycle
128
80.73
20.52
18.64
43.05
38.04
8.2
90.86
88.44
119
78.59
642
Working Capital Days
39.13
26.68
67.2
64.7
63.46
51.09
29.4
36.59
104
35.86
-26.73
6.41
ROCE %
10.74%
11.21%
23.06%
32.51%
29.11%
24.84%
38.87%
12.2%
9.92%
20.38%
3.79%
9.52%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Auro Laboratories insights

63 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

DIIs0.01%Promot.52.40%Others11.02%Public36.56%As ofJun 2026

Documents

Frequently Asked Questions about Auro Laboratories

What does Auro Laboratories Ltd do?
Incorporated in 1989, Auro Laboratories Ltd is in the business of Bulk Drugs[1]
Where is Auro Laboratories Ltd (530233) listed?
Auro Laboratories Ltd trades as AUROLABORATORIESLTD on the NSE and under code 530233 on the BSE.
Which sector does Auro Laboratories Ltd belong to?
Auro Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Auro Laboratories Ltd?
Auro Laboratories Ltd has a market capitalisation of ₹156.08 Cr, which places it in the Small Cap band.
What is the PE ratio of Auro Laboratories Ltd?
Auro Laboratories Ltd trades at a PE ratio of 34.20, on earnings per share of ₹12.48, against a book value of ₹74.36 per share.
What is the 52-week high and low of Auro Laboratories Ltd?
Over the last 52 weeks Auro Laboratories Ltd has traded between ₹159 and ₹317.
What is the Return on Equity (ROE) of Auro Laboratories Ltd?
Auro Laboratories Ltd reported a return on equity of 7.62%. Its debt-to-equity ratio is 1.37.

Company Information

Incorporated in 1989, Auro Laboratories Ltd is in the business of Bulk Drugs[1]

Website aurolabs.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530233.md for Auro Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List